Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank

被引:3
|
作者
Chatzigeorgiou, Charikleia [1 ,2 ]
Taylor, John C. [1 ,3 ]
Elliott, Faye [1 ]
O'Sullivan, Eoin P. [4 ]
Morgan, Ann W. [1 ,2 ,3 ,5 ]
Barrett, Jennifer H. [1 ,2 ]
Mackie, Sarah L. [1 ,2 ,6 ]
机构
[1] Univ Leeds, Sch Med, Leeds, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, England
[3] Univ Leeds, Leeds Inst Data Analyt, Leeds, England
[4] Kings Coll Hosp NHS Fdn Trust, Dept Ophthalmol, London, England
[5] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, England
[6] Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Chapeltown Rd, Leeds LS74SA, England
关键词
epidemiology; polymyalgia rheumatica; giant cell arteritis; co-morbidities; UK Biobank; RISK-FACTORS; PREVALENCE; MULTICENTER; MANAGEMENT; ARTHRITIS; SPECTRUM;
D O I
10.1093/rap/rkad095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The aim was to determine prevalent co-morbidities in cases with PMR or GCA compared with matched controls.Methods This was a nested, cross-sectional case-control study within the UK Biobank, which recruited participants aged 40-69 years. Case status was defined as self-reported prior diagnosis of PMR or GCA. Ten controls per case were matched for age, sex, ethnicity and assessment centre. Associations with selected self-reported co-morbidities were studied using conditional logistic regression.Results Of PMR (n = 1036) or GCA (n = 102) cases, 72% were female, 98% White, and 58% reported current use of glucocorticoids. Mean age was 63 years. At the time of the assessment visit, compared with controls, PMR/GCA cases were more likely to report poor general health and at least several days of low mood in the past 2 weeks. PMR was associated with hypothyroidism [odds ratio (OR) = 1.34; 95% CI = 1.07, 1.67] and ever-use of HRT (OR = 1.26; 95% CI = 1.07, 1.47). Regarding common co-morbidities, PMR and GCA were both associated with hypertension (PMR: OR = 1.21; 95% CI = 1.06, 1.39; GCA: OR = 1.86; 95% CI = 1.23, 2.81) and cataract (PMR: OR = 1.51; 95% CI = 1.19, 1.93; GCA: OR = 3.84; 95% CI = 2.23, 6.60). Additionally, GCA was associated with depression (OR = 3.05; 95% CI = 1.59, 5.85). Neither condition was associated with diabetes.Conclusion Participants with a history of PMR/GCA, including those not currently taking glucocorticoids, rated their health as poorer than matched controls. Some previously described disease associations (hypothyroidism and early menopause) were replicated. Hypertension and cataract, both of which can be exacerbated by long-term glucocorticoid therapy, were over-represented in both diseases, particularly GCA. What does this mean for patients?Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are conditions that are often thought of as affecting older people. To manage these conditions, doctors prescribe long-term steroid treatment. We looked at a database from the UK Biobank study of half a million UK residents aged 40-69 years. In this database, there were 1036 people with PMR and 102 with GCA. We compared each of these people with PMR/GCA with 10 others of the same age and sex who did not have these conditions. We found that people with PMR/GCA had more general health problems and had low mood more often than people without these conditions. Depression was also seen more often in people with GCA than in people without GCA. People with PMR/GCA were also more likely to have high blood pressure and cataract. These are known side-effects of steroid treatment. People with PMR had higher rates of hypothyroidism and were also more likely to have used hormone replacement therapy. Other studies have found similar results. We still do not fully understand why this is. This study focused on people who were diagnosed with PMR or GCA at a younger age than usual. This patient group has not been studied much before. Our findings show that we need to pay attention to the physical and mental health needs of these patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
    Maggi, Paolo
    Santoro, Carmen R.
    Nofri, Marco
    Ricci, Elena
    De Gennaro, Nicolo
    Bellacosa, Chiara
    Schiaroli, Elisabetta
    Orofino, Giancarlo
    Menzaghi, Barbara
    Di Biagio, Antonio
    Squillace, Nicola
    Francisci, Daniela
    Vichi, Francesca
    Molteni, Chiara
    Bonfanti, Paolo
    Gaeta, Giovanni Battista
    De Socio, Giuseppe Vittorio
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [22] RISK OF FRAGILITY FRACTURE OVER 10 YEARS IN POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS: A UK POPULATION STUDY
    Paskins, Zoe
    Whittle, Rebecca
    Hider, Samantha
    Sultan, Alyshah Abdul
    Bucknall, Milica
    Helliwell, Toby
    Roddy, Edward
    Mallen, Christian D.
    RHEUMATOLOGY, 2017, 56 : 85 - 86
  • [23] Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
    Paolo Maggi
    Carmen R. Santoro
    Marco Nofri
    Elena Ricci
    Nicolò De Gennaro
    Chiara Bellacosa
    Elisabetta Schiaroli
    Giancarlo Orofino
    Barbara Menzaghi
    Antonio Di Biagio
    Nicola Squillace
    Daniela Francisci
    Francesca Vichi
    Chiara Molteni
    Paolo Bonfanti
    Giovanni Battista Gaeta
    Giuseppe Vittorio De Socio
    BMC Infectious Diseases, 19
  • [24] Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani, Carlo
    Padoan, Roberto
    Iorio, Luca
    Tomelleri, Alessandro
    Terrier, Benjamin
    Muratore, Francesco
    Dasgupta, Bhaskar
    AUTOIMMUNITY REVIEWS, 2024, 23 (01)
  • [25] The frequency of psychiatric disorder co-morbidities in patients with fibromyalgia: A cross-sectional study in Iran
    Sadr, Sara
    Mobini, Maryam
    Tabarestani, Mohammad
    Parkoohi, Parisa Islami
    Elyasi, Forouzan
    NURSING OPEN, 2023, 10 (07): : 4797 - 4805
  • [26] AZATHIOPRINE IN GIANT-CELL ARTERITIS POLYMYALGIA RHEUMATICA - A DOUBLE-BLIND-STUDY
    DESILVA, M
    HAZLEMAN, BL
    ANNALS OF THE RHEUMATIC DISEASES, 1986, 45 (02) : 136 - 138
  • [27] ANTIBODIES TO INTERMEDIATE FILAMENTS IN POLYMYALGIA RHEUMATICA GIANT-CELL ARTERITIS - A SEQUENTIAL STUDY
    DASGUPTA, B
    DUKE, O
    PANAYI, GS
    HAZLEMAN, B
    BRITISH JOURNAL OF RHEUMATOLOGY, 1987, 26 : 61 - 61
  • [28] ANTIBODIES TO INTERMEDIATE FILAMENTS IN POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS - A SEQUENTIAL STUDY
    DASGUPTA, B
    DUKE, O
    KYLE, V
    MACFARLANE, DG
    HAZLEMAN, BL
    PANAYI, GS
    ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (10) : 746 - 749
  • [29] Co-occurrence of Giant Cell Arteritis and Polymyalgia Rheumatica: Insights from a Retrospective Analysis
    Tiwari, Vivekanand
    Fang, Chih
    Campbell, Emily
    Loomba, Katherine
    Khubchandani, Nisha
    Shah, Shikha
    Rigby, William
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3310 - 3312
  • [30] Recommendations for Early Referral of Patients with Suspected Polymyalgia Rheumatica: An Initiative from the International Giant Cell Arteritis and Polymyalgia Rheumatica Study Group
    Keller, Kresten
    Mukhtyar, Chetan
    Nielsen, Andreas Wiggers
    Hemmig, Andrea
    Mackie, Sarah
    Sattui, Sebastian
    Hauge, Ellen Margrethe
    Dua, Anisha
    Helliwell, Toby
    Neil, Lorna
    Blockmans, Daniel
    Devauchelle, Valerie
    Hayes, Eric
    Venneboer, Annett Jansen
    Monti, Sara
    Ponte, Cristina
    De Miguel, Eugenio
    Matza, Mark
    Warrington, Kenneth
    Byram, Kevin
    Yaseen, Kinanah
    Peoples, Christine
    Putman, Mike
    Lally, Lindsay
    Finikiotis, Michael
    Appenzeller, Simone
    Carmori, Ugo
    Toro Gutierrez, Carlos Enrique
    Backhouse, Elisabeth
    Camila Guerrero, Maria
    Pimentel-Quiroz, Victor
    Keen, Helen
    Owen, Claire
    Daikeler, Thomas
    De Thurah, Annette
    Schmidt, Wolfgang
    Brouwer, Elisabeth
    Dejaco, Christian
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4745 - 4747